Does The Beyond Meat IPO Spell The End Of The Cow? by Jim Lane It’s Thanksgiving week in the United States but we are feasting alternatively on acronyms here in Digestville. I.E., e.g., ICYMI, BYND IPO PDQ, and FYI Perfect Day AKA Muufri JDA w/ ADM. As they said at Bletchley Park, let’s get out the Enigma machine and decode. In New York and California this week, the nutrition side of industrial biotechnology — and specifically, the “beyond the cow moovement is, ahem, mooving faster with news that Beyond Meat has filed for its IPO and Perfect Day has inked a Joint Development Agreement with Archer Daniels Midland ( ADM ) to scale up the production of dairy proteins using fermentation in microflora. Beyond Meat’s placeholder IPO target is $100 million and is supported by Goldman Sachs, J.P. Morgan, Credit Suisse, BofA Merrill Lynch, Jefferies and William Blair in the IPO. What’s driving the action? It’s combination of consumer shift, the industrialization of alternatives,
